Evervie Health signs letter of intent for ten LINAC systems from Elekta

The procurement in numbers

A letter of intent, not a binding purchase

The filing describes the letter as a record of the company’s “present commercial intention to proceed”. It is not a definitive sale and purchase agreement, and it does not oblige Elekta to supply the equipment. The procurement remains subject to the execution of a definitive Purchase and License Agreement, necessary approvals, financing arrangements and other contractual conditions. That agreement will record the final delivery dates and milestones. The filing does not give a date for signing it.

LINAC systems and the operating subsidiary

A linear accelerator, or LINAC, is a machine that delivers high-energy radiation for radiotherapy, a treatment used in cancer care. The filing refers to the equipment as HARMONY linear accelerator systems. The systems are proposed to be operated by Evervie Health’s subsidiary, Optimus Oncology Private Limited. The filing says the separate operating arrangement with Optimus will be subject to applicable approvals and compliances, and it gives no further detail on that arrangement.

Name change and new website

The company also launched a new official website, everviehealth.com, in place of pvpglobal.com, with effect from 20 Oct 2026. The change follows the company’s name change from PVP Ventures Limited to Evervie Health Limited. The filing says the website particulars will be updated in the relevant records, as applicable.

What the letter of intent means for Evervie Health’s shareholders

Until a definitive agreement is executed, the filing does not commit the company to the purchase. The filing does not state the rupee cost of the systems, the financing route, or whether the deal will go ahead. The expected value is given only in US dollars, at US$11–15 million, with payment to be made in Swedish krona. The next dated step is the execution of the definitive Purchase and License Agreement, for which the filing gives no date. The closing share price on 19 Oct 2026 was ₹45.59.

Reference: Original filing (PDF)